본문으로 건너뛰기
그룹별 보기 기록 1739건 · 페이지 34/35

사용금지 화장품 물질 — 부속서 II

부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.

이 부속서 필터링

이 부속서의 구성

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

대조 대상

부속서 II 기록

1739 총
이 목록의 기록, 총 1739건
항목물질CAS최대 농도표시
1678Hymexazol (ISO)3-hydroxy-5-methylisoxazoleCAS 10004-44-1 10004-44-1 —
1679Imiprothrin (ISO)reaction mass of: [2,4- dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl) imidazolidin-3-yl] methyl(1R)-trans-chrysanthemateCAS 72963-72-5 72963-72-5 —
1680Bis(α,α-dimethylbenzyl) peroxideCAS 80-43- 80-43- —
1681TetrafluoroethyleneCAS 116-14-3 116-14-3 —CMR
16826,6'-di-tert-butyl-2,2'-methylenedi-p-cresol[DBMC]CAS 119-47-1 119-47-1 —CMR
1683(5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanonepyriofenoneCAS 688046-61-9 688046-61-9 —CMR
1684(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonatetolpyralateCAS 1101132-67-5 1101132-67-5 —CMR
1685Azamethiphos (ISO)S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphateCAS 35575-96-3 35575-96-3 —CMR
16863-methylpyrazoleCAS 1453-58-3 1453-58-3 —CMR
1687N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamidepydiflumetofenCAS 1228284-64-7 1228284-64-7 —CMR
1688N-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamidesedaxaneCAS 874967-67-6 874967-67-6 —CMR
16894-methylpentan-2-oneisobutyl methyl ketone (MIBK)CAS 108-10-1 108-10-1 —CMR
1690Dimethomorph (ISO)(E,Z)-4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholineCAS 110488-70-5 110488-70-5 —CMR
1691Imazamox (ISO)(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acidCAS 114311-32-9 114311-32-9 —CMR
1692Thiamethoxam (ISO)3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamineCAS 153719-23-4 153719-23-4 —CMR
1693Triticonazole (ISO)(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanolCAS 138182-18-0 138182-18-0 —CMR
1694Desmedipham (ISO)ethyl 3-phenylcarbamoyloxyphenylcarbamateCAS 13684-56-5 13684-56-5 —CMR
1695Ammonium bromideCAS 12124-97-9 12124-97-9 —
1696Dibutyltin bis(2-ethylhexanoate)CAS 2781-10-4 2781-10-4 —
1697Dibutyltin di(acetate)CAS 1067-33-0 1067-33-0 —
1698Tellurium dioxideCAS 7446-07-3 7446-07-3 —
1699Barium diboron tetraoxideCAS 13701-59-2 13701-59-2 —
17002,2-dimethylpropan-1-ol,tribromo derivative3-bromo-2,2-bis(bromomethyl)propan-1-olCAS 36483-57-5 / 1522-92-5 36483-57-5 / 1522-92-5 —
17012,4,6-tri-tert-butylphenolCAS 732-26-3 732-26-3 —
17024,4’-sulphonyldiphenolbisphenol SCAS 80-09-1 80-09-1 —
1703BenzophenoneCAS 119-61-9 119-61-9 —
1704Quinoclamine (ISO)2-amino-3-chloro-1,4-naphthoquinoneCAS 2797-51-5 2797-51-5 —
1705Perfluoroheptanoic acidtridecafluoroheptanoic acidCAS 375-85-9 375-85-9 —
1706methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninatevalifenalateCAS 283159-90-0 283159-90-0 —
17076-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts——
17086-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acidCAS 2156592-54-8 2156592-54-8 —
17096-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid——
1710Theophylline1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dioneCAS 58-55-9 58-55-9 —
17111,3,5-triazine-2,4,6-triaminemelamineCAS 108-78-1 108-78-1 —
1712Fluopicolide (ISO)2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamideCAS 607-285-6 607-285-6 —
1713N-(2-nitrophenyl)phosphoric triamideCAS 874819-71-3 874819-71-3 —
1714N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamideisoflucypramCAS 1255734-28-1 1255734-28-1 —
1715Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide [≥ 78 % syn isomers ≤ 15 % anti isomers relative content]isopyrazamCAS 881685-58-1 881685-58-1 —
1716Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents]CAS 84696-25-3 84696-25-3 —
1717CumeneCAS 98-82-8 98-82-8 —
17182-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylateCAS 15625-89-5 15625-89-5 —
1719Pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetateCAS 7216-95-7 7216-95-7 —
1720N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid)Pentetic Acid (INCI)CAS 67-43-6 67-43-6 —
1721Pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetatePentasodium Pentetate (INCI)CAS 140-01-2 140-01-2 —
1722Acetamiprid (ISO)(1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidineCAS 135410-20-7 / 160430-64-8 135410-20-7 / 160430-64-8 —
1723Pendimethalin (ISO)N-(1-ethylpropyl)-2,6-dinitro-3,4-xylideneCAS 40487-42-1 40487-42-1 —
1724Bentazone (ISO)3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxideCAS 25057-89-0 25057-89-0 —
1725Styrene/Acrylates copolymer (nano) [INCI] Sodium Styrene/Acrylates copolymer (nano) [INCI]CAS 9010-92-8 9010-92-8 —
1726Copper (nano) [INCI] Colloidal Copper (nano) [INCI]CAS 7440-50-8 7440-50-8 —
1727Silver (nano) [1 nm < particle diameter ≤ 100 nm] Silver (massive) [particle diameter ≥ 1 mm]CAS 7440-22-4 7440-22-4 —

이 그룹별 보기 사용 방법

부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.

법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.